VASCULAN Trademark

Trademark Overview

On Wednesday, January 20, 2016, a trademark application was filed for VASCULAN with the United States Patent and Trademark Office. The USPTO has given the VASCULAN trademark a serial number of 86880530. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, February 21, 2024. This trademark is owned by Cumberland Pharmaceuticals Inc.. The VASCULAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in patients with pulmonary hypertension and in patients with Peripheral Artery Disease
vasculan

General Information

Serial Number86880530
Word MarkVASCULAN
Filing DateWednesday, January 20, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, February 21, 2024
Registration Number5281997
Registration DateTuesday, September 5, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 10, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in patients with pulmonary hypertension and in patients with Peripheral Artery Disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 25, 2016
Primary Code005
First Use Anywhere DateWednesday, June 28, 2017
First Use In Commerce DateWednesday, June 28, 2017

Trademark Owner History

Party NameCumberland Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNashville, TN 37203
Party NameCumberland Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNashville, TN 37203
Party NameCumberland Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNashville, TN 37203

Trademark Events

Event DateEvent Description
Wednesday, February 21, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, February 21, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, February 21, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, September 5, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, January 16, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 16, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 16, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 16, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 16, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, September 5, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, April 22, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 22, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 22, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 5, 2017REGISTERED-PRINCIPAL REGISTER
Thursday, August 3, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, August 2, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 1, 2017STATEMENT OF USE PROCESSING COMPLETE
Wednesday, July 5, 2017USE AMENDMENT FILED
Monday, July 31, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 5, 2017TEAS STATEMENT OF USE RECEIVED
Saturday, January 7, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 5, 2017SOU EXTENSION 1 GRANTED
Thursday, January 5, 2017SOU EXTENSION 1 FILED
Thursday, January 5, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, July 5, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 10, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 10, 2016PUBLISHED FOR OPPOSITION
Wednesday, April 20, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 4, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 1, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 14, 2016EXAMINER'S AMENDMENT ENTERED
Monday, March 14, 2016ASSIGNED TO LIE
Monday, March 14, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, March 14, 2016EXAMINERS AMENDMENT E-MAILED
Monday, March 14, 2016EXAMINERS AMENDMENT -WRITTEN
Monday, March 14, 2016ASSIGNED TO EXAMINER
Monday, January 25, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 23, 2016NEW APPLICATION ENTERED

Related Keywords

vasculan patients artery disease peripheral pulmonary preparations pharmaceutical hypertension